Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia

被引：0

作者：

Tedeschi, Alessandra ^{[1
]}

Rossi, Davide ^{[2
]}

Coscia, Marta ^{[3
]}

Vismara, Eleonora ^{[1
]}

Petrizzi, Valeria Belsito ^{[4
]}

Orlandi, Ester ^{[5
]}

Cascavilla, Nicola ^{[6
]}

Scarfo, Lydia ^{[7
]}

Motta, Marina ^{[8
]}

Vitale, Candida ^{[3
]}

Ricci, Francesca ^{[1
]}

De Paoli, Lorenzo ^{[2
]}

D'Arco, Alfonso Maria ^{[4
]}

Gallamini, Andrea ^{[9
]}

Gaidano, Gianluca ^{[10
]}

Morra, Enrica ^{[1
]}

Massaia, Massimo ^{[3
]}

Montillo, Marco ^{[1
]}

机构：

[1] Osped Niguarda Ca Granda, Dept Hematol, Milan, Italy

[2] Amedeo Avogadro Univ, Dept Hematol, Novara, Italy

[3] Univ Turin, Dept Med & Expt Oncol, Sect Hematol, Turin, Italy

[4] Nocera Inferiore Hosp, Dept Internal Med, Nocera Inferiore, Italy

[5] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy

[6] IRCCS, Dept Hematol, San Giovanni Rotondo, Italy

[7] Ist Sci San Raffaele, Lymphoma Unit, Dept Oncohematol, Milan, Italy

[8] Brescia Hosp, Spedali Civili, Dept Hematol, Brescia, Italy

[9] Santa Croce Hosp, Dept Hematol, Cuneo, Italy

[10] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2898.2898

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2898

引用

页数：2

共 50 条

[1] BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL
Tedeschi, A.
Coscia, M.
Rossi, D.
Ricci, F.
D'Arena, G.
Orlandi, E.
Petrizzi, V. Belsito
Scarfo, L.
Vitale, C.
Vismara, E.
Gaidano, G.
Morra, E.
Massaia, M.
Montillo, M.
ANNALS OF ONCOLOGY, 2011, 22 : 173 - 173
[2] Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients
Montillo, Marco
Tedeschi, Alessandra
Gaidano, Gianluca
Coscia, Marta
Petrizzi, Valeria Belsito
Orlandi, Ester
Cascavilla, Nicola
Ghia, Paolo
Motta, Marina
Gallamini, Andrea
Frustaci, Anna Maria
Rossi, Davide
De Paoli, Lorenzo
Nichelatti, Michele
Morra, Enrica
Massaia, Massimo
HAEMATOLOGICA, 2014, 99 (09) : E159 - E161
[3] BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
Tedeschi, A.
Coscia, M.
Rossi, D.
Vismara, E.
Ricci, F.
Vitale, C.
Morra, E.
Gaidano, G.
Massaia, M.
Montillo, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 324 - 324
[4] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Zagoskina, T.
Zotina, E.
Ovsepyan, V.
Shardakov, V.
HAEMATOLOGICA, 2014, 99 : 591 - 591
[5] EFFICACY OF COMBINATION FLUDARABINE AND ALEMTUZUMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Zagoskina, T.
Zotina, E.
Malykh, O.
HAEMATOLOGICA, 2012, 97 : 305 - 305
[6] Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia
McCune, SL
Gockerman, JP
Moore, JO
Decastro, CM
Bass, AJ
Chao, NJ
Long, GD
Vredenburgh, JJ
Gasparetto, C
Adams, D
Payne, N
Rizzieri, DA
LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1007 - 1011
[7] Alemtuzumab Use In Relapsed and Refractory Chronic Lymphocytic Leukemia
Arnason, Jon E.
Brown, Jennifer R.
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 119 - 120
[8] Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Coutre, Steven E.
Flinn, Ian W.
de Vos, Sven
Barrientos, Jacqueline C.
Schreeder, Marshall T.
Wagner-Johnson, Nina D.
Sharman, Jeff P.
Boyd, Thomas E.
Fowler, Nathan
Dreiling, Lyndah
Kim, Yeonhee
Mitra, Siddhartha
Rai, Kanti
Leonard, John P.
Furman, Richard R.
HEMASPHERE, 2018, 2 (03):
[9] Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Kataeva, Elena
Golenkov, Anatoly
Triphonova, Elena
Dudina, Galina
Mitina, Tatyana
Lutskaya, Tatyana
Vysotskaya, Ludmila
Chernykh, Yulliya
Zakharov, Sergey
BLOOD, 2013, 122 (21)
[10] Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial
Cortelezzi, A.
Sciume, M.
Liberati, A. M.
Vincenti, D.
Cuneo, A.
Reda, G.
Laurenti, L.
Zaja, F.
Marasca, R.
Chiarenza, A.
Gritti, G.
Orsucci, L.
Storti, S.
Angelucci, E.
Cascavilla, N.
Gobbi, M.
Mauro, F. R.
Morabito, F.
Fabris, S.
Piciocchi, A.
Vignetti, M.
Neri, A.
Rossi, D.
Giannarelli, D.
Guarini, A.
Foa, R.
LEUKEMIA, 2014, 28 (03) : 642 - 648

← 1 2 3 4 5 →